Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.4M
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
27.1M
-
Shares change
-
+9.45K
-
Total reported value, excl. options
-
$306M
-
Value change
-
+$284K
-
Number of buys
-
37
-
Number of sells
-
-47
-
Price
-
$11.31
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q4 2019
108 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q4 2019.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.1M shares
of 37.4M outstanding shares and own 72.38% of the company stock.
Largest 10 shareholders include WYNNEFIELD CAPITAL INC (2.87M shares), Russell Investments Group, Ltd. (2.87M shares), DIMENSIONAL FUND ADVISORS LP (2.43M shares), NWQ Investment Management Company, LLC (2.11M shares), BlackRock Inc. (2.01M shares), VANGUARD GROUP INC (1.62M shares), Walthausen & Co., LLC (1.18M shares), Legion Partners Asset Management, LLC (1.18M shares), HEARTLAND ADVISORS INC (1.15M shares), and INVESTMENT COUNSELORS OF MARYLAND LLC (852K shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.